DE68903092D1 - Laktamimide in der behandlung arzneiresistenter protozoeninjektionen. - Google Patents

Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.

Info

Publication number
DE68903092D1
DE68903092D1 DE8989120782T DE68903092T DE68903092D1 DE 68903092 D1 DE68903092 D1 DE 68903092D1 DE 8989120782 T DE8989120782 T DE 8989120782T DE 68903092 T DE68903092 T DE 68903092T DE 68903092 D1 DE68903092 D1 DE 68903092D1
Authority
DE
Germany
Prior art keywords
resistant
treatment
protozone
lactamimides
injections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989120782T
Other languages
English (en)
Other versions
DE68903092T2 (de
Inventor
Alan J Bitonti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE68903092D1 publication Critical patent/DE68903092D1/de
Application granted granted Critical
Publication of DE68903092T2 publication Critical patent/DE68903092T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8989120782T 1988-11-10 1989-11-09 Laktamimide in der behandlung arzneiresistenter protozoeninjektionen. Expired - Fee Related DE68903092T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26985888A 1988-11-10 1988-11-10

Publications (2)

Publication Number Publication Date
DE68903092D1 true DE68903092D1 (de) 1992-11-05
DE68903092T2 DE68903092T2 (de) 1993-02-18

Family

ID=23028945

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989120782T Expired - Fee Related DE68903092T2 (de) 1988-11-10 1989-11-09 Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.

Country Status (11)

Country Link
EP (1) EP0370320B1 (de)
JP (1) JPH02256614A (de)
AT (1) ATE81004T1 (de)
AU (1) AU619613B2 (de)
DE (1) DE68903092T2 (de)
DK (1) DK561089A (de)
ES (1) ES2045348T3 (de)
GR (1) GR3006349T3 (de)
IE (1) IE893618L (de)
PH (1) PH27568A (de)
ZA (1) ZA898440B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228748A (en) * 1988-04-20 1991-07-26 Merrell Dow Pharma Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor
JPH09504028A (ja) * 1993-10-21 1997-04-22 ジー．ディー．サール アンド カンパニー 酸化窒素シンターゼ抑制剤として有用なアミジノ誘導体
US5821267A (en) * 1993-10-21 1998-10-13 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
ATE195933T1 (de) * 1994-03-10 2000-09-15 Searle & Co L-n6-(1-iminoethyl)lysin - derivate und ihre verwendung als no-synthase - inhibitoren
US5684008A (en) 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
KR100442561B1 (ko) * 1995-04-20 2004-10-14 지.디. 썰 엘엘씨 ５산화２질소신타아제의억제제로유용한환상아미디노제
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
JP2002517502A (ja) 1998-06-10 2002-06-18 ジー・ディー・サール・アンド・カンパニー 複素二環状及び三環状一酸化窒素シンターゼ阻害剤
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
CN102149679A (zh) * 2008-09-09 2011-08-10 巴斯夫欧洲公司 用于防治动物害虫的吡咯啉-2-基氨基化合物
JP5705742B2 (ja) * 2008-12-08 2015-04-22 アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ アルファ２ｂまたはアルファ２ｂおよびアルファ２ｃアドレノセプターのサブタイプ選択性モジュレーターとしてのｎ‐（１‐フェニル‐２‐アリールエチル）‐４，５‐ジヒドロ‐３ｈ‐ピロール‐２‐アミン化合物
WO2011042565A2 (en) * 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228130A (en) * 1978-10-23 1980-10-14 The B. F. Goodrich Company Coating polymerization reactors with oligomers derived from polyhydric phenols plus a bleach

Also Published As

Publication number Publication date
AU4445089A (en) 1990-05-17
IE893618L (en) 1990-05-10
DK561089D0 (da) 1989-11-09
EP0370320B1 (de) 1992-09-30
AU619613B2 (en) 1992-01-30
DK561089A (da) 1990-05-11
EP0370320A1 (de) 1990-05-30
ATE81004T1 (de) 1992-10-15
PH27568A (en) 1993-08-18
GR3006349T3 (de) 1993-06-21
ZA898440B (en) 1990-07-25
DE68903092T2 (de) 1993-02-18
JPH02256614A (ja) 1990-10-17
ES2045348T3 (es) 1994-01-16

Similar Documents

Publication Publication Date Title
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
DK261490D0 (da) New pharmaceutical compound
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE53376T1 (de) Entzuendungshemmende agentien.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DK166323C (da) Griseolsyrederivater og farmaceutiske midler indeholdende disse
ES2058343T3 (es) Piridinas disubstituidas.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
ATE76579T1 (de) Interferon-zusammensetzungen.
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
IT8321740A0 (it) Derivati dell'isoindolina e composizioni terapeutiche che li comprendono come principio attivo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee